• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

In Vitro Diagnostic (IVD) Trends and Market Update: November 2023

$3,750.00 – $7,500.00

Clear
SKU: 23-046 Categories: Diagnostics Market Research, in vitro diagnostic, IVD Tags: Antibody, Antigen, Clinical Chemistry, COVID-19, diabetes, Flow Cytometry, Immunoassay, in vitro diagnostics, ivd, mass spectrometry, molecular, Personalized Medicine, POC, sequencing Pages: 40
  • Description
  • Table of Contents
  • Latest reports

Description

In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient.

IVD Trends and Market Update: November 2023 by Kalorama Information is the most up-to-date resource on these and other key market trends. Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q3 2023 with a publication date of November 2023.

There are some growing segments in the market that have attracted industry attention. Among these are Point-of-Care, next-generation sequencing (NGS), cancer testing, and companion diagnostics technologies. Immunochemistry, mass spectrometry. Gene testing and molecular diagnostics are also segments of great market interest, anticipated to be a big part of the future of IVD.

Trends highlighted throughout Q3 2023 include:

  • Multiplex testing is proliferating
  • Continued interest in adopting AI technologies

Kalorama Information maintains its unwavering dedication to examining the IVD market and its dynamically evolving landscape. The company’s excellence in market analysis is attributed to the extensive expertise of its authors and the market research firm’s resolute commitment to providing the most precise and up-to-date data.

In IVD Trends and Market Update: November 2023, you’ll discover out:

  • What’s Driving Growth in the IVD Market in Q3 and the last half of 2023?
  • What Major Trends are Affecting the Market in Q3 and the last half of 2023?
  • How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2023?
  • What Product Trends and New Developments Will Shape the IVD Market in the last half of 2023?

Table of Contents

Chapter 1: Worldwide IVD Market – October 2023 Update

IVD Market Demand and Growth

Figure 1-1: Q3 Segment Performance Commentary, 2023

  • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2023 ($ million) (Clinical Chemistry; Immunoassays – non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab]; Hematology – Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology – Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
  • Figure 1-2: IVD Segment Performance, Q1 2023 – Q4 2023e ($MN)
  • Figure 1-3: IVD Segment Performance (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other), Total Market Value, 2023 ($MN) Estimated

COVID-19 Diagnostic Markets

  • Table 1-2: COVID-19 Product Sales, by Segment (Immunoassay [Antigen, Serology], Molecular, Rapid [POC Professional, POC At-Home]), 2023 ($ millions)

Effect of COVID-19 on Market Segments

  • Table 1-3: IVD Market (excluding and with COVID-19), 2023 ($ millions)
  • Figure 1-4: IVD Market Distribution, by Segment (COVID-19 Assays and Instruments, IVD Market excluding COVID-19 Assays and Instruments), 2023 (%)
  • Figure 1-5: IVD Market by COVID-19 and non-COVID Markets, Quarterly Performance, 2023 Estimated  ($ millions)
  • Table 1-4: Global In Vitro Diagnostic Market, by Segment (Clinical Chemistry; Immunoassays –  non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab]; Hematology – Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Coagulation [PT/INR]; Histology/cytology; d-dimer; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; POC, OTC diabetes; POC, OTC other; POC, professional/hospital), YoY Growth 2022-2023 (%)
  • Figure 1-6: Global In Vitro Diagnostic Market, by Segment (Clinical Chemistry; Immunoassays –  non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c – lab]; Hematology – Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Coagulation [PT/INR]; Histology/cytology; d-dimer; Nucleic acid assays; Blood grouping/typing; Blood bank molecular – NAT Screens; POC, OTC diabetes; POC, OTC other; POC, professional/hospital), YoY Growth 2022-2023 (%)

 

Chapter 2: Product Trends and New Developments

Selected New – Q3 2023 – Core IVD Product Launches, Developments and Trends

Clinical Chemistry

Flow Cytometry

Immunoassay

Mass Spectrometry

Molecular

Personalized Medicine

POC

Sequencing

Selected COVID-19 Developments – Q3 2023

  • Figure 2-1: COVID-19 Test Market, by Type (Antigen, Molecular, Serology, Rapid), Q1-Q4 2023 ($ millions)

Antigen/Antibody

Molecular

 

Chapter 3: Top IVD Market Participant Results

Selected Competitive Leader Updates

  • Figure 3-1: IVD Segment Growth, by Leading Competitors (Abbott Diagnostics, Becton Dickinson, bioMérieux, Danaher, Exact Sciences, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific), Change in Sales, 2022-2023 (%)
  • Figure 3-2: Changes in Market Distribution for IVD Sales, 2020-2023 – Roche and Abbott Battle for #1 Spot
  • Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche, 2020-2023 ($ millions)

Q3 M&A Activity

Table 3-1: Q3 2023 Merger and Acquisition Activity

Abbott Laboratories

  • Table 3-2: Abbott Corporate Summary

Becton Dickinson and Co

  • Table 3-3: Becton Dickinson Corporate Summary

bioMérieux SA

  • Table 3-4: bioMérieux Corporate Summary

Danaher Corporation

  • Table 3-5: Danaher Corporation Summary

Hologic, Inc.

  • Table 3-6: Hologic Corporate Summary

QuidelOrtho Corporation

  • Table 3-7: QuidelOrtho Corporate Summary

Roche Diagnostic

  • Table 3-8: Roche Diagnostic Corporate Summary

Siemens Healthineers

  • Table 3-9: Siemens Healthineers Corporate Summary

Sysmex Corporation

  • Table 3-10:  Sysmex Corporate Summary

Thermo Fisher Scientific

  • Table 3-11: Thermo Fisher Scientific Corporate Summary

 

Chapter 4: New Opportunities

Multiplex Testing

Next-Generation Sequencing

Artificial Intelligence Future Trends

Disruptive Technologies

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00
  • Placeholder image

    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    $4,500.00 – $9,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease

    $1,995.00 – $3,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany,... Remote Patient Monitoring and Telehealth Markets, 13th Edition
Scroll to top